Palpable spleen size is differently prognostic in primary and secondary myelofibrosis
Leuk Lymphoma
.
2023 Apr;64(4):893-896.
doi: 10.1080/10428194.2023.2179360.
Epub 2023 Feb 17.
Authors
Marko Lucijanic
1
2
,
Ivan Krecak
3
4
,
Ena Soric
1
,
Davor Galusic
5
6
,
Hrvoje Holik
7
8
,
Vlatka Perisa
8
9
,
Martina Moric Peric
10
,
Ivan Zekanovic
10
,
Rajko Kusec
1
2
Affiliations
1
Hematology Department, University Hospital Dubrava, Zagreb, Croatia.
2
University of Zagreb School of Medicine, Zagreb, Croatia.
3
Department of Internal Medicine, General Hospital Sibenik, Sibenik, Croatia.
4
University of Rijeka School of Medicine, Rijeka.
5
Department of Hematology, University Hospital of Split, Split, Croatia.
6
University of Split School of Medicine, Split, Croatia.
7
Department of Internal Medicine, "Dr. Josip Bencevic" General Hospital, Ul. Andrije Stampara, Slavonski Brod, Croatia.
8
University of Osijek Faculty of Medicine, Osijek, Croatia.
9
Department of Hematology, Osijek University Hospital, Osijek, Croatia.
10
Department of Internal Medicine, General Hospital Zadar, Zadar, Croatia.
PMID:
36799562
DOI:
10.1080/10428194.2023.2179360
No abstract available
Publication types
Letter
MeSH terms
Humans
Nitriles
Primary Myelofibrosis* / diagnosis
Prognosis
Pyrazoles
Spleen*
Substances
Pyrazoles
Nitriles